# ARSJ

## Overview
The ARSJ gene encodes a protein that belongs to the arylsulfatase family, specifically classified as a sulfatase enzyme. This family of enzymes is primarily involved in the hydrolysis of sulfate esters, a critical biochemical process in various cellular functions. The ARSJ protein, although highly homologous to other sulfatases such as ARSB, exhibits unique characteristics, including a lack of expected sulfatase activity against common substrates. This suggests a potentially distinct biological role or substrate specificity. The gene's structure is notable for its minimal exon composition, which is atypical for sulfatases, and it undergoes alternative splicing that results in different C-terminal sequences. Despite its structural similarities with other sulfatases, the ARSJ protein's precise functional role and its implications in human health and disease remain areas of active research (Obaya2006Molecular).

## Structure
The ARSJ gene encodes a protein that is part of the sulfatase family, characterized by its involvement in the hydrolysis of sulfate esters. The ARSJ protein is predicted to be 596 amino acids in length and has two possible variants at the 3' end, differing in the last 10 amino acids due to a small intron processing event. These variants result in different C-terminal sequences: STCHSGVTCG and KPANLAR (Obaya2006Molecular).

The genomic organization of ARSJ is unique among sulfatases, typically having only two main coding exons, which is fewer than most other sulfatases (Obaya2006Molecular). Despite its high homology with ARSB, ARSJ does not exhibit the expected sulfatase activity against common substrates like 4-MUS, although it is a good substrate for formylglycine enzyme (FGE) transformation (Obaya2006Molecular).

The ARSJ protein shares a high degree of similarity with other known sulfatases, particularly in the catalytic domain where the active site amino acids are conserved (Obaya2006Molecular). However, specific details on the secondary, tertiary, or quaternary structures, as well as prominent folds or post-translational modifications, are not provided in the available context.

## Clinical Significance



## References


[1. (Obaya2006Molecular) Alvaro J. Obaya. Molecular cloning and initial characterization of three novel human sulfatases. Gene, 372:110â€“117, May 2006. URL: http://dx.doi.org/10.1016/j.gene.2005.12.023, doi:10.1016/j.gene.2005.12.023. This article has 22 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.gene.2005.12.023)